Outcome analysis of acute myeloid leukemia patients treated with high dose daunorubicin. Biomedical Research and Therapy, [S. l.], v. 6, n. 9, p. 3347–3351, 2019. DOI: 10.15419/bmrat.v6i9.562. Disponível em: https://preservation.bmrat.org/index.php/BMRAT/article/view/562.. Acesso em: 15 nov. 2024.